Subject(s)
Leiomyoma/diagnosis , Lung Neoplasms/secondary , Tuberculosis, Miliary/diagnosis , Uterine Neoplasms/pathology , Adult , Biopsy/methods , Diagnosis, Differential , Female , Humans , Leiomyoma/surgery , Lung Neoplasms/diagnosis , Lung Neoplasms/surgery , Thoracic Surgery, Video-Assisted , Tomography, X-Ray Computed , Uterine Neoplasms/diagnostic imaging , Uterine Neoplasms/surgeryABSTRACT
A case of fetal chest wall cystic lymphangioma diagnosed prenatally at 28 weeks' gestation is reported. Ultrasound examination showed a multilocular, large cystic mass (10 x 22 x 29 mm) on the left side of the fetus in the area of the lower chest and upper abdomen, without color flow imaging. Magnetic resonance imaging was used to evaluate the extent and the tissue characteristics of the lesion. Two months after birth the lymphangioma was surgically removed, following an infection and a rapid increase in size. The case is discussed, and a short review of the literature is reported.
Subject(s)
Fetal Diseases/diagnosis , Lymphangioma, Cystic/diagnosis , Soft Tissue Neoplasms/diagnosis , Adult , Female , Humans , Lymphangioma, Cystic/surgery , Magnetic Resonance Imaging , Pregnancy , Soft Tissue Neoplasms/surgery , Thoracic Wall , Ultrasonography, PrenatalABSTRACT
AIM: The aim of this study was to evaluate the efficacy and tolerance of a high dose of vaginal misoprostol for outpatient medical management of missed abortion. METHODS: Three doses of 400 mug misoprostol were administered intravaginally every 4 h daily, for a maximum period of 3 days, to 108 women with uneventful first trimester pregnancy failure. RESULTS: A total of 98 women (90.7%) were managed successfully, with 74 (68.5%) of them within the first 24 h. The mean dose of misoprostol administered was 1,113.0 microg (range 400-3,600 microg), and the mean time required was 19.5 h (range 7-65 h). Only 6 out of 108 women (9.3%) required surgical intervention as the result of retained products of conception. The side effect profile was minimal. CONCLUSION: This protocol of 400 mug intravaginally misoprostol every 4 h as three daily doses for a maximum of 3 days, may offer an efficacious and safe alternative to the outpatient management of first-trimester missed abortion.
